Watching this wedge drop seeing if we start to recover from this higher low and retesting supply zone in this next few months. Im focusing atleast the mid level of this wedge. Still a trap range from that drop I feel a choppy accumulation build up but we will see how long it maintains this range
19M float looks to be accumulated by large players, I'm long here. Target #1 Pivot to 4.50 Target #2 pivot to 5 Good luck and size appropriately as always.
Dyadic International signed a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. The Rubic Consortium is made up of promoters of the project representing public health, medical, academia, vaccine technology, technology transfer and economics sectors. Arrangement includes C1 COVID-19 vaccine technology transfer and licensing...
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants Expanding existing COVID-19 vaccine research collaboration which began in July 2020. Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two or more of the current and future COVID-19 variants (e.g., tetravalent or quadrivalent COVID-19...
Greetings Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, feel free to send us message (inbox). Pra Trading : - Please care for Money Management - Have a good psychology - Do not be hurry to open position and do not do...
LONG-TERM: 4hr and Daily classic bullish divergence at the bottom of a long term range, honestly the closer you can enter to the support the better, so maybe if the market is red tomorrow because of futures, it can provide a more optimal entry than the one shown here. (Not financial advice and the market is currently uncertain)
Just based on Pivot Points in the past.
=====TARGET PRICE $8.25====== BREAKOUT LEVEL / ENTRY $7.10 COMPANY PROFILE Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture...